Damage to the CNS is characterized by activation of microglia and astroglia, a phenomenon termed reactive gliosis. These cellular reactions have been implicated in both regeneration and degeneration of the CNS. Damage-induced production of cytokines and chemokines has been linked to the initiation of gliosis using several injury models, including exposure to known neurotoxicants. The Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway is a down-stream effector of cytokines and activation of this pathway is associated with gliosis. In particular, the transcription factor STAT3 is critical for astroglial response to CNS damage. Here, we used brain slices from mice treated with the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) to examine astroglial STAT3 activation responses. 12 hours post MPTP (12.5 mg/kg, s.c.) or saline treatment, C57Bl/6 female mice were sacrificed by decapitation and coronal slices of brain were prepared. Striatum was dissected and assayed for activated STAT-3 (Tyr705 phosphorylation). Phospho-STAT3 was present in slices from MPTP treated mice immediately following sacrifice while absent in control mice, recapitulating in vivo observations. These data suggest that activated STAT3 is pre-served in brain slices. Striatal slices were then exposed to phosphate free oxygenated buffer for various times. After 45 minutes both MPTP treated and control striata expressed p-STAT3, indicating that MPTP induced phosphorylation is retained ex vivo and that STAT3 activation can also result from slice injury. Production of cytokines upstream of STAT3 was examined by RT-PCR. Messenger RNA for CNTF and IL-6 was not altered while mRNA for MCP-1 and LIF was increased. Finally we determined that AG490, a JAK inhibitor, and lavendustin A, a tyrosine kinase inhibitor, could diminish STAT3 phosphorylation in slices. These data suggest that activation of STAT3 is an early event in both toxicant and slice-induced glial activation. In addition, this investigation establishes the brain slice preparation method as a reliable model to examine reactive gliosis.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.